<DOC>
	<DOC>NCT00120718</DOC>
	<brief_summary>The purpose of the study is to evaluate how the rho kinase inhibitor, fasudil, affects vascular function in patients with atherosclerosis and hyperlipidemia.</brief_summary>
	<brief_title>The Effect of Fasudil on Vascular Function in Humans</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Fasudil</mesh_term>
	<criteria>Coronary artery disease Hyperlipidemia OR Healthy adults Unstable angina, myocardial infarction or revascularization within 3 months Symptomatic heart failure Creatinine &gt; 3.0 mg/dl Liver enzymes &gt; 3X upper limit of normal Chronic hypoxia Significant anemia Chronic inflammatory disease Pregnancy Willing to withdraw statins for duration of study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>